Nutriband Financials
NTRB Stock | USD 6.57 0.37 5.97% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.74 | 0.92 |
|
|
The essential information of the day-to-day investment outlook for Nutriband includes many different criteria found on its balance sheet. An individual investor should monitor Nutriband's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Nutriband.
Net Income |
|
Nutriband | Select Account or Indicator |
Please note, the presentation of Nutriband's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nutriband's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nutriband's management manipulating its earnings.
Nutriband Stock Summary
Nutriband competes with Quoin Pharmaceuticals, Longeveron LLC, RenovoRx, Virax Biolabs, and Indaptus Therapeutics. Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Nutriband operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US67092M2089 |
CUSIP | 67092M208 |
Location | Florida; U.S.A |
Business Address | 121 South Orange |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.nutriband.com |
Phone | 407 377 6695 |
Currency | USD - US Dollar |
Nutriband Key Financial Ratios
Return On Equity | -0.6 | ||||
Operating Margin | (4.62) % | ||||
Price To Sales | 34.06 X | ||||
Revenue | 2.09 M | ||||
Gross Profit | 804.61 K |
Nutriband Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 9.9M | 12.7M | 9.5M | 7.5M | 8.6M | 5.5M | |
Other Current Liab | (161.1K) | (164.3K) | (256.8K) | (1.0) | (0.9) | (0.85) | |
Net Tangible Assets | (1.9M) | (1.4M) | 5.6M | 2.8M | 3.2M | 3.3M | |
Net Debt | 1.6M | (4.8M) | (1.8M) | (251.7K) | (226.5K) | (237.8K) | |
Retained Earnings | (11.8M) | (18.0M) | (22.5M) | (28.0M) | (25.2M) | (23.9M) | |
Accounts Payable | 940.6K | 639.5K | 534.7K | 680.1K | 782.2K | 473.8K | |
Cash | 152.0K | 4.9M | 2.0M | 492.9K | 566.9K | 982.0K | |
Net Receivables | 109.3K | 71.4K | 113.0K | 148.6K | 170.9K | 179.5K | |
Inventory | 52.8K | 131.6K | 229.3K | 168.6K | 193.9K | 203.6K | |
Total Liab | 2.8M | 880.4K | 883.4K | 1.1M | 1.2M | 996.5K | |
Short Long Term Debt | 1.5M | 14.1K | 19.7K | 127.2K | 146.3K | 253.2K | |
Total Current Assets | 314.2K | 5.5M | 2.7M | 1.0M | 1.2M | 1.3M | |
Short Term Debt | 1.6M | 52.8K | 82.3K | 161.5K | 185.7K | 278.1K | |
Intangible Assets | 1.0M | 926.9K | 780.4K | 667.3K | 767.4K | 494.7K | |
Common Stock | 6.3K | 7.8K | 7.8K | 8.9K | 8.0K | 10.3K | |
Net Invested Capital | 8.8M | 12.0M | 8.7M | 6.6M | 7.6M | 6.2M | |
Net Working Capital | (2.3M) | 4.7M | 1.9M | 22.8K | 26.2K | 24.9K | |
Capital Stock | 6.3K | 7.8K | 7.8K | 8.9K | 8.0K | 7.7K |
Nutriband Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 280.7K | 118.4K | 8.3K | 75.8K | 87.2K | 68.0K | |
Total Revenue | 943.7K | 1.4M | 2.1M | 2.1M | 2.4M | 2.5M | |
Gross Profit | 361.3K | 504.3K | 750.4K | 862.1K | 991.4K | 1.0M | |
Operating Income | (2.6M) | (3.9M) | (4.1M) | (4.9M) | (4.4M) | (4.2M) | |
Ebit | (2.7M) | (6.1M) | (4.5M) | (5.4M) | (4.9M) | (4.6M) | |
Ebitda | (2.5M) | (5.7M) | (4.1M) | (5.1M) | (4.6M) | (4.4M) | |
Cost Of Revenue | 582.4K | 917.8K | 1.3M | 1.2M | 1.4M | 1.5M | |
Income Before Tax | (2.9M) | (6.2M) | (4.5M) | (5.5M) | (4.9M) | (5.2M) | |
Net Income | (3.2M) | (8.4M) | (4.8M) | (5.5M) | (4.9M) | (5.2M) | |
Income Tax Expense | 280.7K | 2.2M | 327.3K | (2.0) | (2.3) | (2.18) | |
Net Interest Income | (349.8K) | (118.4K) | (8.3K) | (59.0K) | (67.8K) | (71.2K) |
Nutriband Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (10.2K) | (78.8K) | (97.7K) | 60.7K | 54.7K | 57.4K | |
Investments | 67.0K | (81.6K) | (79.3K) | (51.8K) | (46.6K) | (48.9K) | |
Change In Cash | 141.8K | 4.7M | (2.9M) | (1.5M) | (1.3M) | (1.3M) | |
Net Borrowings | 430.3K | (194.9K) | (1.6M) | (17.8K) | (16.0K) | (16.8K) | |
Depreciation | 169.7K | 318.3K | 369.0K | 287.7K | 330.9K | 169.2K | |
Other Non Cash Items | 363.9K | 2.2M | 614.5K | 704.2K | 809.8K | 800.3K | |
Net Income | (2.9M) | (6.2M) | (4.5M) | (5.5M) | (4.9M) | (5.2M) | |
End Period Cash Flow | 152.0K | 4.9M | 2.0M | 492.9K | 566.9K | 993.3K | |
Change To Netincome | 955.3K | 2.0M | 3.5M | 1.3M | 1.5M | 1.7M | |
Free Cash Flow | (297.1K) | (2.9M) | (3.1M) | (3.6M) | (3.2M) | (3.1M) |
Nutriband Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutriband's current stock value. Our valuation model uses many indicators to compare Nutriband value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutriband competition to find correlations between indicators driving Nutriband's intrinsic value. More Info.Nutriband is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Nutriband's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutriband's earnings, one of the primary drivers of an investment's value.Nutriband Systematic Risk
Nutriband's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nutriband volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Nutriband correlated with the market. If Beta is less than 0 Nutriband generally moves in the opposite direction as compared to the market. If Nutriband Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nutriband is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nutriband is generally in the same direction as the market. If Beta > 1 Nutriband moves generally in the same direction as, but more than the movement of the benchmark.
Nutriband Thematic Clasifications
Nutriband is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Medical Equipment | View |
Today, most investors in Nutriband Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nutriband's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nutriband growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Nutriband March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nutriband help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nutriband. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nutriband based on widely used predictive technical indicators. In general, we focus on analyzing Nutriband Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nutriband's daily price indicators and compare them against related drivers.
Downside Deviation | 6.34 | |||
Information Ratio | 0.1171 | |||
Maximum Drawdown | 54.72 | |||
Value At Risk | (9.34) | |||
Potential Upside | 17.09 |
Complementary Tools for Nutriband Stock analysis
When running Nutriband's price analysis, check to measure Nutriband's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutriband is operating at the current time. Most of Nutriband's value examination focuses on studying past and present price action to predict the probability of Nutriband's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutriband's price. Additionally, you may evaluate how the addition of Nutriband to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |